BackAlbany Molecular Research Overview

Albany Molecular Research Goodwill

Albany Molecular Research's goodwill is $240M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$238.70M
↑ 39.84% YoYΔ $68.00M vs prior year quarter

Peer average

Loading

Albany Molecular Research Goodwill History

Loading

Albany Molecular Research vs. peers: Goodwill Comparison

Loading

Albany Molecular Research Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Albany Molecular Research (AMRI) FAQ

As of the most recent data (June 2017), AMRI shows a goodwill of $240M. That compares with $170M in the prior-year period — up 39.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMRI's goodwill is now $240M (was $170M) — a 39.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Albany Molecular Research is outperforming or lagging.

Tracking AMRI's goodwill over time shows whether Albany Molecular Research is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $170M in the prior-year period — up 39.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Albany Molecular Research's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $240M) with ownership activity and broader fundamentals.